Browse drugs

…omising and cost-effective biomarker for predicting response to immune checkpoint inhibitors (ICIs) across various tumor types. This study evaluates the uti…

…carcinoma (MASH-HCC) has been reported to be less responsive to immune checkpoint inhibitors, which may be associated with metabolic reprogramming of tumour…

…n early-stage disease before immune suppression is established. Immune checkpoint inhibitors have demonstrated benefit in the adjuvant setting (postsurgery)…

…The introduction of immune checkpoint inhibitors (ICI) has revolutionized the treatment of many solid tumors includin…

…C) present a significant challenge due to poor prognosis. While immune checkpoint inhibitors (ICIs) have been standard treatments for NSCLC, their efficacy …

…g and enhancing adaptive immunity through therapeutic vaccines, immune checkpoint inhibitors or T cell-based therapies represents a promising approach for H…

… varied depending on whether a neurologist was involved or not (steroids 90.7% vs. 81.8%; IVIg 25.6% vs. 9.1%; PLEX 16.3% vs. 9.1%). Alt…

…Introduction Immune Checkpoint Inhibitors (ICI) have revolutionised management of many cancers, but are a…

… Despite remarkable advances in cancer immunotherapy, including immune checkpoint inhibitors and adoptive cell therapies, many patients fail to achieve dura…

…c MGMT-deficient G1/G2 PanNET treated with TMZ, with or without capecitabine, reportedly experienced histological progression to G3 disease …

…lite unstable CRC responds exceptionally well to treatment with immune checkpoint inhibitors, thereby proving that CRC is in principle amenable to immunothe…

…Background Immune checkpoint inhibitors and immune-activating cytokines constitute a valuable resource …